One year after its parent firm began exploring the use of its technology for the life-science market, NanoBioDiscovery is preparing to make its debut in the proteomics space with a nanotechnology-based platform for assay development.

NanoBioDiscovery, a division of NanoInk, expects to launch its Dip Pen Nanolithography technology-based instrumentation during the third quarter at the same time that it will start offering services based on the technology, Bruce Dudzik, senior director of NanoBioDiscovery, told ProteoMonitor this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.